Funder: Alzheimer's Association

Due Dates: August 6, 2025 (Letter of Intent) | September 24, 2025 (Full Application, by invitation)

Funding Amounts: Up to $1,000,000 total (direct + indirect) over 2–3 years; indirects capped at 10% for nonprofits, not allowed for for-profits.

Summary: Accelerates IND-enabling preclinical development of innovative, disease-modifying therapeutics for Alzheimer's and related dementias.

Key Information: LOI is required and only invited applicants may submit a full proposal.